Funding is available to support multidisciplinary research in prostate cancer through the Patrick C. Walsh Prostate Cancer Research Fund.

For the Fiscal Year 2026 funding cycle, we anticipate awarding up to $1.0 million in funding.

Pilot project awards of $100,000 or multi-PI project awards of up to $200,000 will made available to support cutting-edge multidisciplinary scientific research on prostate cancer.

Funding is open to all JHU affiliated faculty.  Partnership with a Brady Urological Institute faculty member is highly encouraged, but not required. Applications from outside the field of prostate cancer are strongly encouraged, with the intent to attract researchers into the field. These applications should include a Urology co-PI and focus on addressing prostate cancer.  All awardees will be required to submit an abstract and present a poster or research talk at the annual Donald S. Coffey Urology Research Day Symposium. Funds not utilized within the defined funding period will be returned to the Walsh Fund.

Application Deadline: 5:00 PM on August 1, 2025
Funding notified by August 29, 2025
Project Period: September 1, 2025 to August 31, 2026

Patrick C Walsh Prostate Cancer Research Fund Pilot Project

• $100,000 Budget
• 2 year funding period
• PI salary should not be supported

Patrick C Walsh Prostate Cancer Research Multi-PI Pilot Project

• $200,000 Budget
• 2 year funding period
• Interdisciplinary Multi-PI projects encouraged 
• PI salary should not be supported

Applications should be submitted using the application portal at https://projects.rlogx.com/project/57C8A7BD38E6E0814460B6482C0DEA22 . Please be certain that you are applying to the Patrick C. Walsh Prostate Cancer Research Fund and specify the targeted funding mechanism. All applications should include a 250-word summary that is understandable to a layperson.  Questions regarding the application process should be directed to Brandy Yeater via email (dyeater1@jhmi.edu). 

Tamara Lotan, M.D. 
Director, Urology Research Laboratories

Sam Denmeade, M.D., and Shawn Lupold, Ph.D.
SPORE Directors